Infectious Diseases Archives - Page 76 of 104

News
Three-drug combo proves effective against multidrug-resistant UTIs
October 29, 2018
SAN FRANCISCO – A drug combo including EDTA proved superior to meropenem in the treatment of complicated urinary tract infections.
News
Septic shock: Innovative treatment options in the wings
October 28, 2018
BOSTON - Trials evaluating vitamin C for refractory septic shock have demonstrated a large mortality impact.
News
Endoscopy-related infections found higher than expected, prophylaxis overused
October 27, 2018
ATLANTA – “The potential for this becoming a bit of a monster is enhanced by the widespread use of prophylactic antimicrobials during endoscopy.”
Article
Daptomycin/fosfomycin: A new standard for MRSA bacteremia?
October 25, 2018
Better survival was seen for MRSA bacteremia at 7 days using the combo vs. monotherapy.
News
FDA clears Abbott’s Influenza A & B 2, Strep A 2 assays
October 25, 2018
The Influenza A & B 2 assay can detect and differentiate influenza A and B in 13 minutes, while the Strep A 2 assay detects group A streptococcus bacterial nucleic acid in 6 minutes.
News
FDA approves Xofluza for treatment of influenza
October 24, 2018
The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.
Opinion
How much more proof do you need?
October 16, 2018
Why are there still proponents for lengthy IV therapy when oral therapy works just as well?
News
Stepdown to oral ciprofloxacin looks safe in gram-negative bloodstream infections
October 15, 2018
SAN FRANCISCO – A comparison of patients with gram-negative bloodstream infections showed low 90-day treatment failure in those who switched from IV to oral ciprofloxacin within 5 days.
News
In C. difficile, metronidazole may not benefit ICU patients on vancomycin
October 14, 2018
SAN FRANCISCO – Try fecal transplant instead.
News
Need blood STAT? Call for a drone
October 14, 2018
BOSTON – Autonomous unmanned aerial vehicles bring blood to remote hospitals in Africa, but a U.S.-based system will need to overcome significant regulatory hurdles.